Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1991
11/21/1991EP0457701A1 Derivatives of endogenous mediators, their salts, process for preparation, application and compositions containing them
11/21/1991EP0457565A2 Milk-protein hydrolyzates and compositions for use as hair and skin treating agent
11/21/1991EP0457532A1 Monoclonal antibody which inhibits the biological action of platelet factor 4
11/21/1991EP0457438A2 Conjugate compounds containing aza-macrocycles, and processes for their preparation
11/21/1991EP0457371A1 Method for the isolation of the tissue protein PP4
11/21/1991EP0457370A1 Method for the pasteurization of the tissue protein PP4
11/21/1991EP0457223A1 Stabilized fibroblast growth factor composition
11/21/1991EP0457195A2 Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same
11/21/1991EP0456842A1 Medicinal application of m-csf
11/21/1991EP0456812A1 Megakaryocyte production
11/21/1991EP0456766A1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE
11/21/1991EP0456758A1 Anaphylatoxin-receptor ligands
11/21/1991EP0456662A1 Vaccine for the preventative treatment of infection of liver fluke in ruminants
11/21/1991EP0456642A1 Somatotropin analogs
11/21/1991DE4115559A1 Antitumormittel mit verminderter toxizitaet auf der basis von cytostatika und xanthogenaten Anti-tumor agent with reduced toxicity on the basis of cytostatics and xanthates
11/20/1991CN1056245A Bcrf1 antagonists for treating epstein-barr virus infections
11/20/1991CN1056240A Inhibition nf allograft and concordant xenograft rejection
11/19/1991US5066794 Process for preparing a disaccharide derivative
11/19/1991US5066787 Blood coagulation inhibiting proteins, processes for preparing them and their uses
11/19/1991US5066786 Adsorption on a clean porous glass column, elution with sodium chloride and acetic acid
11/19/1991US5066783 Antiviral peptides and means for treating herpes infections
11/19/1991US5066782 Retrovirus capable of causing AIDS, means and method for detecting it in vitro
11/19/1991US5066644 Derivatives of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
11/19/1991US5066642 Adamantyl comprising tripeptides, derivatives and hydrochlorides thereof, their preparation and use
11/19/1991US5066592 Inhibition of fibrinogen induced aggregation of human platelets, anticoagulants
11/19/1991US5066590 Superoxide dismutase combined with a poly(alkylene oxide)
11/19/1991US5066489 Synergistic Effective Amount Of IL-2, A Lymphokine, And DTIC(Dacarbazine)
11/19/1991US5066487 Antisudoral composition comprising dibasic aluminium salts of acylated amino acids
11/19/1991US5066436 Microencapsulating Bioactive Substances In Biocompatible Polymers
11/19/1991CA1292344C Peptides and therapeutic applications thereof
11/19/1991CA1292343C Di- and tri-peptidal renin inhibitors
11/19/1991CA1292182C Intrapulmonary delivery of polypeptide growth factors and cytokines
11/18/1991WO1991018001A1 Trans-dominant suppressor genes for oligomeric proteins
11/18/1991CA2083164A1 Trans-dominant suppressor genes for oligomeric proteins
11/18/1991CA2017163A1 Thioproline derivatives
11/17/1991WO1991017764A1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding
11/16/1991WO1991018019A1 Soluble single chain t cell receptors
11/16/1991WO1991017757A1 Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates
11/16/1991CA2064067A1 Anti-tumor agents having reduced toxicity on the basis of cytostatic agents and xanthogenates
11/16/1991CA2047733A1 Soluble single chain t cell receptors
11/16/1991CA2042569A1 Stabilized fgf composition
11/16/1991CA2042437A1 Immunologic enhancement of the somatogenic effect of somatotrophin with an antibody
11/16/1991CA2042295A1 Endogen mediator derivatives, salts thereof, process for their preparation, applications and compositions containing such
11/15/1991WO1991018099A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin
11/15/1991WO1991018012A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties
11/15/1991CA2059649A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties
11/15/1991CA2042468A1 Compositions of and treatment with biologically active peptides having d-amino acid residues
11/15/1991CA2042442A1 Peptide compound and its preparation
11/14/1991WO1991017249A1 Interleukin-1 antagonist and uses thereof
11/14/1991WO1991017248A1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
11/14/1991WO1991017185A1 Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
11/14/1991WO1991017184A1 Modified interleukin-1 inhibitors
11/14/1991WO1991017183A1 Proteins with fibroblast growth factor receptor activity
11/14/1991WO1991017181A1 Cyclized and linear therapeutic peptides
11/14/1991WO1991017180A1 Peptides derived from human tumour necrosis factor alpha and useful against intracellular malarial parasites
11/14/1991WO1991017179A1 Peptide analogs to proteins of the immunoglobulin superfamily
11/14/1991WO1991017174A1 Dna encoding human 5-ht1d receptors and uses thereof
11/14/1991WO1991017171A1 NUCLEOTIDE SEQUENCE ENCODING A 52 kDa Ro/SSA AUTOANTIGEN
11/14/1991WO1991016931A1 Clot imaging agents and use thereof
11/14/1991WO1991016929A1 A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
11/14/1991WO1991016924A1 Enhancing the association of exogenous peptides with class i mhc molecules on immune system cells
11/14/1991WO1991016922A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
11/14/1991WO1991016921A1 Method and composition for the treatment of cancer
11/14/1991WO1991016919A1 Synthetic peptides for arterial imaging
11/14/1991WO1991016918A1 Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents
11/14/1991WO1991016917A1 Method of treating gastric ulcers and obesity
11/14/1991WO1991016916A1 Antineoplastic agent
11/14/1991WO1991016904A1 Method for treating retroviral infections in mammals
11/14/1991WO1991015222A3 Method of predisposing mammals to accelerated tissue repair
11/14/1991WO1991014704A3 Treatment of polycystic ovarian disease
11/14/1991WO1991012023A3 Hybrid reagents capable of selectively releasing molecules into cells
11/14/1991DE4014510A1 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie Variant CD44-oberflaechenproteine, this encoding c-dna sequences, antibodies against these proteins and their use in the diagnosis and therapy
11/14/1991CA2374571A1 Dna encoding human 5-ht1d receptors and uses thereof
11/14/1991CA2081890A1 Cyclized and linear therapeutic peptides
11/14/1991CA2081774A1 Interleukin-1 antagonist and uses thereof
11/14/1991CA2080493A1 Synthetic peptides for arterial imaging
11/13/1991EP0456418A2 Treatment of clostridium difficile diarrhoea and pseudomembranous colitis
11/13/1991EP0456332A1 Purified interleukin 1 and DNA coding for interleukin 1 and their preparation, vectors containing such DNA and their preparation and use in transforming hosts to permit expression of interleukin 1
11/13/1991EP0456200A1 Mutein of granulocyte colony stimulating factor (G-CSF)
11/13/1991EP0456188A1 Therapeutic agent for hepatocirrhosis
11/13/1991EP0456185A2 Renin inhibitors
11/13/1991EP0456153A1 Galenical aqueous formulations containing erythropoietin and use thereof
11/13/1991EP0456152A2 Peptidamides, their process of preparation and the agents containing these peptides as fibrin-thrombin clotting inhibitors
11/13/1991EP0456039A2 Renin inhibiting amino acid derivatives
11/13/1991EP0455833A1 Amino acid derivative
11/13/1991EP0455818A1 Proces for the production of substances be-16627
11/13/1991EP0455741A1 Method for detecting inhibitors of tat protein
11/13/1991EP0455726A1 Treatment of leukocyte dysfunction with gm-csf
11/13/1991EP0455722A1 Processes for producing polypeptide inhibitors of platelet activation and methods, combinations and compositions using them
11/13/1991EP0455719A1 SYNERGISTIC COMPOSITION CONTAINING A MAGAININ PEPTIDE AND A PGLa PEPTIDE
11/13/1991EP0455682A1 Polypeptides having a human beta-adrenergic receptor activity, and playing a role in lipolytic response, nucleic acids coding for these polypeptides and use of said polypeptides for screening substances which act on these polypeptides.
11/13/1991EP0444129A4 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
11/13/1991EP0412115A4 Hybrid peptides and methods of their use
11/13/1991EP0236385B1 A superoxide dismutase
11/13/1991EP0180596B1 Method of inhibiting binding of von willebrand factor to human platelets and inducing interaction of platelet with vessel walls
11/13/1991CN1056125A Soluble, truncated gamma-interferon receptors
11/13/1991CN1056105A Peptides with bradykinin-antagonistic action
11/12/1991WO1991018101A1 Process for producing protein
11/12/1991WO1991018100A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity
11/12/1991WO1991018014A1 Anti-viral therapy
1 ... 2992 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 ... 3163